Cryofocus Medtech （shanghai）Co.,Ltd.
康沣生物
Cryofocus Medtech （shanghai）Co.,Ltd.
Biotech/Healthcare
Kangfeng Bio focuses on applying cryoablation minimally invasive interventional therapy in the cardiovascular field, with six major product lines including cryoablation for atrial fibrillation and renal artery denervation for treating resistant hypertension. Compared with the nitrous-oxide-based…
Latest round: Series B (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.